| Literature DB >> 30891784 |
Javid Sadri Nahand1, Sima Taghizadeh-Boroujeni2, Mohammad Karimzadeh1, Sarina Borran3, Mohammad Hossein Pourhanifeh4, Mohsen Moghoofei5, Farah Bokharaei-Salim1, Sajad Karampoor1, Amir Jafari6, Zatollah Asemi4, Alireza Tbibzadeh1, Afshin Namdar7, Hamed Mirzaei4.
Abstract
Cervical cancer is as a kind of cancer beginning from the cervix. Given that cervical cancer could be observed in women who infected with papillomavirus, regular oral contraceptives, and multiple pregnancies. Early detection of cervical cancer is one of the most important aspects of the therapy of this malignancy. Despite several efforts, finding and developing new biomarkers for cervical cancer diagnosis are required. Among various prognostic, diagnostic, and therapeutic biomarkers, miRNA have been emerged as powerful biomarkers for detection, treatment, and monitoring of response to therapy in cervical cancer. Here, we summarized various miRNAs as an employable platform for prognostic, diagnostic, and therapeutic biomarkers in the treatment of cervical cancer.Entities:
Keywords: Human papillomavirus; cervical cancer; diagnosis; exosome; microRNA; therapy
Mesh：
Substances：
Year: 2019 PMID： 30891784 DOI： 10.1002/jcp.28457
Source DB: PubMed Journal: J Cell Physiol ISSN： 0021-9541 Impact factor: 6.384